Key result
LVEF <30% linked to ~3.6-fold higher mortality vs preserved LVEF in STEMI.
Why the study?
Clinical characteristics and outcomes for patients with STEMI and reduced LVEF in low-income and middle-income countries were not well described.
Cohort (n=3,597)
Yes
Among STEMI patients in India, reduced LVEF is highly prevalent and strongly associated with 1-year mortality, compounded by poor long-term adherence to guideline-directed medical therapy.
Answers are grounded in this paper and cite their sources.
Reduced LVEF stratifies 1-year mortality risk after STEMI; extends observational data but leaves open effects of GDMT adherence interventions.
AIMS: To describe clinical characteristics and outcomes for those with STEMI and reduced left ventricular ejection fraction (LVEF) in low-income and middle-income countries (LMICs). METHODS AND RESULTS: Adults presenting with STEMI to two government-owned tertiary care centres in Delhi, India were prospectively enrolled in the North India ST-elevation myocardial infarction (NORIN-STEMI) registry. LVEF was evaluated at presentation and clinical characteristics were compared across LVEF categories. Overall, 3597 patients were included, of whom 468 (13%) had LVEF >50%, 1482 (41%) had mildly reduced LVEF (40-49%), 1357 (38%) had moderately reduced LVEF (30-39%), and 290 (8%) had severely reduced LVEF (<30%). Presentation delay >24 h, prior MI, and hyperlipidaemia were associated with decreasing LVEF category. Although most patients with reduced LVEF were discharged on appropriate guideline-directed therapies, adherence at 1 year was low (ACE inhibitor/ARB 91% to 41%, beta blocker 98% to 78%, aldosterone receptor antagonist 69% to 6%). After multivariable adjustment, a Cox regression model showed moderately reduced LVEF (HR 1.77, 95% CI 1.20, 2.60) and severely reduced LVEF (HR 3.63, 95% CI 2.41, 5.48) were associated with increased risk of all-cause mortality compared with LVEF ≥50%. CONCLUSIONS: On presentation for STEMI, almost 90% of NORIN-STEMI participants had at least mildly reduced LVEF and almost half had LVEF <40%. Patients with LVEF <40% had significantly higher risk of mortality at 1 year, and adherence to guideline-directed therapies at 1 year was poor. Systematic initiatives to improve access to timely revascularization and guideline-directed therapies are essential in advancing STEMI care in LMICs.
No takes yet. Share an insight, caveat, or question.
Hendrickson et al. (2022) conducted a cohort in ST-elevation myocardial infarction (STEMI) (n=3,597). Severely reduced LVEF (<30%) vs. LVEF ≥50% was evaluated on all-cause mortality (HR 3.63, 95% CI 2.41-5.48). Severely reduced LVEF was associated with an increased risk of all-cause mortality compared with LVEF ≥50% among patients with STEMI.
Synapse has enriched 10 related papers. Consider them for comparative context: